Analytical and bioanalysis
Explore analytical and bioanalytical technologies supporting pharmaceutical development and manufacturing, including chromatography, mass spectrometry, spectroscopy, bioassays, method validation, impurity testing and sample preparation to ensure product quality, safety and regulatory compliance.
Latest in analytical and bioanalysis
Article
Strategies for scaling complex next-generation biologics
As biologic drug formats grow more sophisticated, scalable success depends on embedding manufacturability, analytics and quality thinking into molecular design from the very beginning of development.
News
IMS Solutions launches ‘steroid fingerprint’ diagnostic technology
A new Imperial College London and University of Birmingham spinout is developing mass spectrometry-based tests to improve the diagnosis and stratification of conditions linked to disordered steroid metabolism.
Upcoming webinars
Modernising pharma QA/QC laboratories: preparing for a more connected, compliant future
Join this webinar to discover how modern QA/QC laboratories are embracing digital transformation to enhance compliance, workflows and data integrity to build a more connected, future-ready pharmaceutical quality ecosystem.
From passive to active air monitoring in aseptic filling: a risk-based approach to replacing settle plates
In this webinar, Particle Measuring Systems will share a case study of a biopharmaceutical company developing and applying a structured global rationale for the implementation of continuous viable environmental monitoring with a single-use microbial impactor within aseptic manufacturing environments.
The impact of negative control stability on recombinant endotoxin testing
In this webinar, FUJIFILM Wako Chemicals Europe GmbH will present the results of a study evaluating how NC stability in endotoxin detection reagents affects assay performance.
Building quality and consistency into accelerated cell and gene therapy development
How can cell and gene therapy manufacturers move programmes forward faster without compromising quality, scalability or regulatory readiness?
Modernising pharma QA/QC laboratories: preparing for a more connected, compliant future
From passive to active air monitoring in aseptic filling: a risk-based approach to replacing settle plates
The impact of negative control stability on recombinant endotoxin testing
Building quality and consistency into accelerated cell and gene therapy development
On demand webinars in analytical and bioanalysis
- Previous
- Next
Join now
Unlock exclusive industry insights
- Bookmark articles and resources to access anytime
- Enjoy free access to industry leading resources, webinars and insights
- Stay informed with the latest news and breakthroughs in drug discovery
- Receive updates and recommendations tailored to your research interests
Reports and whitepapers in analytical and bioanalysis
Pharma Horizons: Nitrosamines
EPR’s 2026 nitrosamines report covers the key developments in manufacturing, quality, regulation, analytical development and beyond.
Articles in analytical and bioanalysis
Article
Strategies for scaling complex next-generation biologics
As biologic drug formats grow more sophisticated, scalable success depends on embedding manufacturability, analytics and quality thinking into molecular design from the very beginning of development.
Article
Nitrosamines: from detection to understanding
Manufacturers are facing a new generation of nitrosamine challenges as NDSRIs demand more sophisticated analytical and risk management strategies.
